Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TCAF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | WNT3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | RBMS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | USP37 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | ANXA7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | KDR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | WBP2NL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HNRNPH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TMEM208 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |